| Bioavailability of Dabigatran and Amiodarone After Multiple Oral Administrations of Dabigatran Etexilate With or Without Amiodarone as Single Dose in Healthy Male and Female Volunteers (NCT02171026) | Boehringer Ingelheim | 2006-04-01 |
| Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia (NCT00316095) | Boehringer Ingelheim | 2006-04-01 |
| Relative Bioavailability of Different Oral Viramune Extended Release Formulations Compared to Viramune® Oral Suspension in Healthy Male Volunteers (NCT02192463) | Boehringer Ingelheim | 2006-04-01 |
| Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated With a Fixed-dose Combination of Telmisartan and Hydrochlorothiazide (NCT02248129) | Boehringer Ingelheim | 2006-04-01 |
| J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term Observation (NCT00659581) | Boehringer Ingelheim | 2006-04-01 |
| Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia (NCT02245555) | Boehringer Ingelheim | 2006-04-01 |
| Effect of Spiriva® on Health-related Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Who Stopped Smoking During Treatment. (NCT02172547) | Boehringer Ingelheim | 2006-04-01 |
| Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension (NCT00281593) | Boehringer Ingelheim | 2006-04-01 |
| Relative Bioavailability of Tiotropium and Salmeterol After Inhalation of a Fixed Combined Dose Compared to Monocomponents in Healthy Male Volunteers (NCT02254174) | Boehringer Ingelheim | 2006-03-01 |
| Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive Symptoms (NCT00297778) | Boehringer Ingelheim | 2006-03-01 |
| A Randomised Placebo-Controlled Phase II Study of Continuous Maintenance Treatment With BIBF 1120 Following Chemotherapy in Patients With Relapsed Ovarian Cancer (NCT00710762) | Boehringer Ingelheim | 2006-03-01 |
| Assessment of Electrophysiological Effects of Dabigatran Etexilate as Single Dose on the QT Interval in Healthy Female and Male Subjects. (NCT02170987) | Boehringer Ingelheim | 2006-03-01 |
| Efficacy and Tolerability CVI (A 12-week, Double-blind, Randomised, Placebo-controlled, Multicentre Trial (CVI) (NCT00292435) | Boehringer Ingelheim | 2006-03-01 |
| A Multi-centre 3-arm Randomised Phase II Trial of BIBF 1120 Versus BIBW 2992 Versus Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Hormone-resistant Prostate Cancer (NCT00706628) | Boehringer Ingelheim | 2006-03-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 14332 CL Powder in Healthy Male Subjects (NCT02211989) | Boehringer Ingelheim | 2006-02-01 |
| TELSYS - TELmisartan Effectiveness in Isolated SYStolic Hypertension Versus Systolic/Diastolic Hypertension Patients Aged 55 or Older (NCT02242877) | Boehringer Ingelheim | 2006-02-01 |
| Phase II Study on the Antiviral Activity and Safety of BILR 355 BS in HIV-1 Infected, NNRTI-treated Patients (NCT00294372) | Boehringer Ingelheim | 2006-02-01 |
| Relative Bioavailability of Tipranavir (TPV)/Ritonavir (RTV) at Steady State Administered as Oral Solutions vs. Capsules in the Fed and Fasted State in Healthy Volunteers (NCT02227017) | Boehringer Ingelheim | 2006-02-01 |
| First Presentation of Parkinson Disease Patients to Neurologist (NCT00802178) | Boehringer Ingelheim | 2006-02-01 |
| Observational Non-interventional Study With Viramune® in Combination With Truvada® in HIV-infected Patients (NCT00543803) | Boehringer Ingelheim | 2006-02-01 |
| Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS) (NCT02248142) | Boehringer Ingelheim | 2006-02-01 |
| Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism (NCT00291330) | Boehringer Ingelheim | 2006-02-01 |
| Case-Control Viramune (Nevirapine) Toxicogenomics Study (NCT00310843) | Boehringer Ingelheim | 2006-02-01 |
| A Randomised, Double-blind, Crossover Study of Ba679BR Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00292448) | Boehringer Ingelheim | 2006-02-01 |
| Evaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique. (NCT00267917) | Boehringer Ingelheim | 2006-01-17 |
| Effects of Tipranavir (With Ritonavir) Capsule and Liquid Formulation on Cytochrome P450 and P-glycoprotein Activity in Healthy Volunteers (NCT02243553) | Boehringer Ingelheim | 2006-01-01 |
| Effect of Spiriva® 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Proven Hyperinflation (NCT02172521) | Boehringer Ingelheim | 2006-01-01 |
| Study to Evaluate the Effect of Micardis® / MicardisPlus® on Metabolic Parameters in Patients With Essential Hypertension and Diabetes Mellitus (NCT02242825) | Boehringer Ingelheim | 2006-01-01 |
| Study to Evaluate the Effect of the Treatment With Micardis® or MicardisPlus® on Blood Pressure (NCT02242864) | Boehringer Ingelheim | 2006-01-01 |
| Open-label Follow-up Trial of Fixed Dose Combination of Telmisartan + Hydrochlorothiazide in Hypertensive Patients (NCT00267943) | Boehringer Ingelheim | 2006-01-01 |
| Efficacy (Bronchoprotection) and Safety of Orally Inhaled BI 1744 CL in Patients With Intermittent Asthma (NCT00928668) | Boehringer Ingelheim | 2006-01-01 |
| Pharmacokinetics (PK) of Tipranavir/Ritonavir, Ribavirin, Pegylated Interferon (Peg INF) in Hepatitis C (HCV) Subjects With Mild Hepatic Impairment and in HCV, Hepatitis B (HBV), Hepatitis D Infected Subjects or Alcoholic Cirrhosis With Moderate Hepatic Impairment (NCT02259855) | Boehringer Ingelheim | 2006-01-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BI 1744 CL in Healthy Male and Female Volunteers (NCT02171806) | Boehringer Ingelheim | 2006-01-01 |
| Safety, Tolerability and Pharmacokinetics of BIBW 2948 BS for HandiHaler® in Healthy Male Volunteers (NCT02216461) | Boehringer Ingelheim | 2006-01-01 |
| Safety, Pharmacodynamics and Pharmacokinetics After Single Oral Administration of Dabigatran Etexilate Capsule in Healthy Subjects (NCT02171455) | Boehringer Ingelheim | 2006-01-01 |
| Pharmacokinetic of Tadalafil Co-administered With Tipranavir/Ritonavir to Healthy Male Volunteers (NCT02253862) | Boehringer Ingelheim | 2005-12-01 |
| Single Dose Ranging Study of BI 1744 CL (Olodaterol) in Chronic Obstructive Pulmonary Disease (NCT01809262) | Boehringer Ingelheim | 2005-12-01 |
| Electrophysiological Effects of Tipranavir Co-administered With Ritonavir on the QT Interval in Healthy Female and Male Subjects (NCT02248883) | Boehringer Ingelheim | 2005-12-01 |
| Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate (NCT00262600) | Boehringer Ingelheim | 2005-12-01 |
| Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Pulmonary Disease (NCT02231320) | Boehringer Ingelheim | 2005-12-01 |
| BI 6727 Administered Intravenously Every 3 Weeks in Patients With Solid Tumours (NCT02273388) | Boehringer Ingelheim | 2005-11-04 |
| Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities (NCT00242814) | Boehringer Ingelheim | 2005-11-03 |
| Study to Determine the Effects of Multiple-dose Omeprazole on the Single-dose Pharmacokinetics of Tipranavir (TPV) Coadministered With Ritonavir (RTV) in Healthy Adult Volunteers (NCT02253875) | Boehringer Ingelheim | 2005-11-01 |
| Blood Pressure Reduction in Danish General Practice (BRIDGE) (NCT00244660) | Boehringer Ingelheim | 2005-11-01 |
| Study to Assess the Influence of Three Different α-antagonists and Placebo on the Extent of Weekly Phenylephrine-induced Mydriasis at Three Different Concentrations of Phenylephrine in Healthy Male Volunteers (NCT02266537) | Boehringer Ingelheim | 2005-11-01 |
| Oral Treatment With BIBF 1120 Together With Docetaxel and Prednisone in Patients With Hormone Refractory Prostate Cancer (NCT02182219) | Boehringer Ingelheim | 2005-11-01 |
| Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension (NCT00257491) | Boehringer Ingelheim | 2005-11-01 |
| Effects of TPV/r on the Pharmacokinetics of Carbamazepine in Healthy Adult Volunteers (NCT02253849) | Boehringer Ingelheim | 2005-11-01 |
| A Study With BIBF 1120 in Patients With Hormone Refractory Prostate Cancer (NCT02182063) | Boehringer Ingelheim | 2005-11-01 |
| A Dose Response Study of Dabigatran Etexilate(BIBR 1048) in Pharmacodynamics and Safety in Patients With Non-valvular Atrial Fibrillation in Comparison to Warfarin (NCT01136408) | Boehringer Ingelheim | 2005-11-01 |
| In Vitro/in Vivo Correlation (IVIVC) for Oral Slow Release (SR) Tablets Pramipexole in Healthy Male Volunteers (NCT02260024) | Boehringer Ingelheim | 2005-10-01 |
| In Vivo Specificity of KUC 7483 CL Co-administered With Bisoprolol, Propranolol, and Acipimox in Healthy Male Subjects (NCT02256722) | Boehringer Ingelheim | 2005-10-01 |
| Study to Investigate the Safety and Efficacy of Alesion® in Japanese Paediatric Patients With Urticaria (NCT02238249) | Boehringer Ingelheim | 2005-10-01 |
| Pharmacokinetics/Bioavailability of BIBF 1120 Administered to Healthy Male Volunteers (NCT02182076) | Boehringer Ingelheim | 2005-10-01 |
| Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Comparison to a Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (NCT02231346) | Boehringer Ingelheim | 2005-10-01 |
| Dose Escalation Study of BIBF 1120 in Patients With Advanced Gynaecological Malignancies (NCT02182245) | Boehringer Ingelheim | 2005-10-01 |
| Telmisartan80/HCTZ25 Versus Telmisartan80/HCTZ12.5 in Hypertension Not Responding to Telmisartan80/HCTZ12.5 (NCT00239369) | Boehringer Ingelheim | 2005-10-01 |
| A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery. (NCT00246025) | Boehringer Ingelheim | 2005-10-01 |
| Efficacy and Tolerability of Ambroxol Lozenge 20 mf in Relieving Pain of Sore Throat in Pat. With Acute/Viralpharyngitis (NCT00148499) | Boehringer Ingelheim | 2005-10-01 |
| Metabolism and Pharmacokinetics of [14C]-BIBF 1120 in Healthy Male Volunteers (NCT02182154) | Boehringer Ingelheim | 2005-10-01 |
| Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00153075) | Boehringer Ingelheim | 2005-09-26 |
| Efficacy, Pharmacokinetics and Safety Comparison of Salmeterol Inhalation Powder Administered Via the HandiHaler® 2 and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02242227) | Boehringer Ingelheim | 2005-09-01 |
| Salmeterol Inhalation Powder Administered as the Xinafoate Salt From Hard Polyethylene Capsules Via the HandiHaler® 2, and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02238106) | Boehringer Ingelheim | 2005-09-01 |
| Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension (NCT00168779) | Boehringer Ingelheim | 2005-09-01 |
| Pharmacokinetics of Salmeterol Via HandiHaler® in Healthy Male Volunteers (NCT02254187) | Boehringer Ingelheim | 2005-09-01 |
| Study to Evaluate the Effect of Multiple Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Warfarin, Omeprazole, Caffeine, and Dextromethorphan in Healthy Male Volunteers (NCT02256813) | Boehringer Ingelheim | 2005-09-01 |
| The Effect of Multiple Oral Doses of BI 1356 BS on Pharmacokinetics, Safety and Tolerability of Multiple Oral Doses of Simvastatin and on the Pharmacokinetics of Its Metabolite Simvastatin Acid in Healthy Male Volunteers (NCT02183623) | Boehringer Ingelheim | 2005-09-01 |
| Bioavailability of BI 1356 BS and Metformin After Co-administration Compared to the Bioavailability of BI 1356 BS Alone and Metformin Alone in Healthy Male Volunteers (NCT02183506) | Boehringer Ingelheim | 2005-09-01 |
| Dose Escalation of BIBF 1120 Combined With Pemetrexed in Advanced Non Small Cell Lung Cancer (NCT02182102) | Boehringer Ingelheim | 2005-09-01 |
| A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® to Control the Early Morning BP Rise (SURGE II) (NCT02242396) | Boehringer Ingelheim | 2005-08-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1356 BS as Tablet in Patients With Type 2 Diabetes (NCT02183415) | Boehringer Ingelheim | 2005-08-01 |
| Study to Investigate the Effect of KUC 7483 CL on the QT/QTc Interval of the ECG in Comparison to Placebo and Moxifloxacin in Healthy Male and Female Volunteers (NCT02256735) | Boehringer Ingelheim | 2005-08-01 |
| Relative Bioavailability of 1 mg and 10 mg BI 1356 BS as Powder in the Bottle (PIB) to 1 mg and 10 mg BI 1356 BS as Tablets as Single Oral Administration in Healthy Male Volunteers Including the Influence of Food on the Bioavailability of 10 mg BI 1356 BS (NCT02180503) | Boehringer Ingelheim | 2005-08-01 |
| Efficacy and Safety of Oral Treatment With BIBF 1120 ES in Advanced Non-small-cell Lung Cancer (NCT02182050) | Boehringer Ingelheim | 2005-08-01 |
| Bioequivalence of Telmisartan/ HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Male Volunteers II (NCT02262858) | Boehringer Ingelheim | 2005-08-01 |
| High Dose Trial in COPD (NCT00128440) | Boehringer Ingelheim | 2005-08-01 |
| Pharmacokinetics and Safety Comparison of Tiotropium Inhalation Powder Administered as the Bromide Salt From Hard Polyethylene Capsule Via the HandiHaler® 2 and Spiriva® HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02242266) | Boehringer Ingelheim | 2005-07-28 |
| Investigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL) (NCT00243087) | Boehringer Ingelheim | 2005-07-01 |
| Dose Finding Study in COPD (NCT00122434) | Boehringer Ingelheim | 2005-07-01 |
| Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function (NCT02170571) | Boehringer Ingelheim | 2005-07-01 |
| Study to Evaluate the Effect of Multiple Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Midazolam in Healthy Male Volunteers (NCT02256748) | Boehringer Ingelheim | 2005-06-01 |
| Study of New Tablet Formulations and Suspension Formulation Compared to Current (1B) Formulation of BILR 355 BS in Healthy Male Volunteer Subjects (NCT02259868) | Boehringer Ingelheim | 2005-06-01 |
| Lendormin D® Tablet (Drug Use Result Survey) (NCT02224014) | Boehringer Ingelheim | 2005-06-01 |
| A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung Cancer (NCT02182232) | Boehringer Ingelheim | 2005-06-01 |
| Pharmacoscintigraphic Investigation Into the Absorption of Nevirapine When Released Into Different Parts of the Gastro-intestinal Tract in Healthy Males (NCT02191189) | Boehringer Ingelheim | 2005-05-01 |
| Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and Pruritus (NCT02238236) | Boehringer Ingelheim | 2005-05-01 |
| BIBW 2992 After Administration of Docetaxel in Patients With Advanced Solid Tumors (NCT02171676) | Boehringer Ingelheim | 2005-05-01 |
| Study to Evaluate the Efficacy of Duloxetine in Outpatients With Major Depressive Disorder and Pain (NCT02232555) | Boehringer Ingelheim | 2005-05-01 |
| Bioequivalence Study of Tipranavir Stored at Controlled Temperature Compared With Tipranavir Stored at Controlled Refrigerated Conditions, Orally Co-administered With Ritonavir in Healthy Male and Female Volunteers (NCT02253888) | Boehringer Ingelheim | 2005-05-01 |
| Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With and Without Renal Impairment (NCT02182024) | Boehringer Ingelheim | 2005-04-01 |
| Safety, Pharmacokinetics and Pharmacodynamics After Multiple Oral Doses of BIBR 1048 MS Capsule in Healthy Japanese Male Subjects (NCT02171000) | Boehringer Ingelheim | 2005-04-01 |
| Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mg (NCT00146341) | Boehringer Ingelheim | 2005-04-01 |
| Ambroxol Lozenges 20mg in Relieving the Pain of Sore Throat in Adolescent Patients With Acute Viral Pharyngitis (NCT00144274) | Boehringer Ingelheim | 2005-04-01 |
| Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary Disease (NCT02177318) | Boehringer Ingelheim | 2005-04-01 |
| Study of Pharmacokinetic Interaction Between Kaletra® (LPV/r) and BILR 355 BS Plus Ritonavir in Healthy Subjects (NCT02256826) | Boehringer Ingelheim | 2005-04-01 |
| Observational Study of METALYSE® in Patients With Acute Myocardial Infarction In Russian Federation (NCT02191670) | Boehringer Ingelheim | 2005-04-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1356 BS in Patients With Type 2 Diabetes (NCT02183350) | Boehringer Ingelheim | 2005-04-01 |
| The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) (NCT02245542) | Boehringer Ingelheim | 2005-04-01 |
| Dose Escalation Trial of BIBW 2992 Administration in Combination With Docetaxel in Patients With Advanced Solid Tumors (NCT02171741) | Boehringer Ingelheim | 2005-04-01 |
| Special Survey Long-term Treatment With Tiotropium on COPD (NCT00638183) | Boehringer Ingelheim | 2005-04-01 |